Who makes IV [14C]PF-06865571?

IV [14C]PF-06865571 is developed by Pfizer.

What development phase is IV [14C]PF-06865571 in?

IV [14C]PF-06865571 is in Phase 1.

What are the side effects of IV [14C]PF-06865571?

Common side effects include Diarrhoea, Conjunctivitis allergic, Urine abnormality, Throat irritation, Upper-airway cough syndrome, Dermatitis contact.

Last reviewed 2026-04-20 · How we verify

IV [14C]PF-06865571

Pfizer · Phase 1 active Small molecule Quality 5/100

At a glance

Generic name	IV [14C]PF-06865571
Sponsor	Pfizer
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

Diarrhoea
Conjunctivitis allergic
Urine abnormality
Throat irritation
Upper-airway cough syndrome
Dermatitis contact
Pruritus
Flushing

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

IV [14C]PF-06865571 CI brief — competitive landscape report
IV [14C]PF-06865571 updates RSS · CI watch RSS
Pfizer portfolio CI